FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma

(2013) E. E. Santo et al.   CANCER RESEARCH

Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non-Small Cell Lung Cancer Cells

(2013) H. Yamaguchi et al.   CLINICAL CANCER RESEARCH

PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells

(2013) Wanyeon Kim et al.   PHARMACOLOGICAL RESEARCH

IGF1 Receptor Signaling Regulates Adaptive Radioprotection in Glioma Stem Cells

(2013) Satoru Osuka et al.   STEM CELLS

The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer

(2012) Mudan Lu et al.   MEDICAL ONCOLOGY

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

(2012) Stephan P Tenbaum et al.   NATURE MEDICINE

Primary culture and immortalization of human fallopian tube secretory epithelial cells

(2012) Alison M Karst et al.   Nature Protocols

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance

(2012) Fung Zhao et al.   Frontiers of Medicine

FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization

(2011) J.-L. Su et al.   CANCER RESEARCH

Resist or die: FOXO transcription factors determine the cellular response to chemotherapy

(2011) Ana R. Gomes et al.   CELL CYCLE

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

(2011) A. M. Karst et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia

(2010) S. M. Kornblau et al.   CLINICAL CANCER RESEARCH

Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients

(2009) Min Fei et al.   CANCER INVESTIGATION

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

(2009) U. B. McGovern et al.   MOLECULAR CANCER THERAPEUTICS

Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells

(2009) Anne S Dejean et al.   NATURE IMMUNOLOGY

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

(2009) Miguel F. Segura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

(2008) Ann K. Folkins et al.   GYNECOLOGIC ONCOLOGY

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective

(2008) E A Jarboe et al.   HISTOPATHOLOGY

New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact

(2008) Keren Levanon et al.   JOURNAL OF CLINICAL ONCOLOGY

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

(2008) Ron Firestein et al.   NATURE

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

(2008) Jer-Yen Yang et al.   NATURE CELL BIOLOGY

The UCSC Genome Browser Database: update 2009

(2008) R. M. Kuhn et al.   NUCLEIC ACIDS RESEARCH

The FoxO code

(2008) D R Calnan et al.   ONCOGENE

FOXOs, cancer and regulation of apoptosis

(2008) Z Fu et al.   ONCOGENE

FOXO3A genotype is strongly associated with human longevity

(2008) B. J. Willcox et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis

(2007) Tomohiro Nakamura et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression

(2007) Christopher R. Rathbone et al.   MUSCLE & NERVE